a public good project by the
Synthesis
Company
of California

© 2026

Gili Regev‐Yochay | doi.page

0 works0 citations0 h-index

Gili Regev‐Yochay

Tel Aviv University(IL)Sheba Medical Center(IL)

Publications by Year

Research Areas

SARS-CoV-2 and COVID-19 Research, Pneumonia and Respiratory Infections, Respiratory viral infections research, COVID-19 Clinical Research Studies, Antimicrobial Resistance in Staphylococcus

Most-Cited Works

→ Covid-19 Breakthrough Infections in Vaccinated Health Care Workers(2021)1,475 cited
→ Antibiotics in agriculture and the risk to human health: how worried should we be?(2014)558 cited
→ Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection(2021)456 cited
→ BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers(2021)369 cited
→ SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact(2021)351 cited
→ Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients(2021)350 cited
→

Association Between Carriage of <EMPH TYPE="ITAL">Streptococcus pneumoniae</EMPH> and <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> in Children

(2004)

297 cited

→ Nasopharyngeal Carriage ofStreptococcus pneumoniaeby Adults and Children in Community and Family Settings(2004)281 cited

→ Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection(2022)273 cited

→ Interference between Streptococcus pneumoniae and Staphylococcus aureus : In Vitro Hydrogen Peroxide-Mediated Killing by Streptococcus pneumoniae(2006)203 cited